Latest news

CommercialJune 9, 2026

Ascidian & Lilly Pen RNA Exon Editing Agreement for Genetic Kidney Issues

Boston-based Ascidian Therapeutics has indicated that although nearly any gene may be editable, that capability alone does not justify...

InsightsJune 9, 2026

Top 10 Trends Redefining the Future of Medical Affairs

Executive Summary Medical affairs is undergoing one of the most significant transformations in its history. Traditionally positioned as a bridge between...

CommercialJune 9, 2026

Travere Licenses Civorebrutinib From Everest Medicines in Deal Worth Up to $1.14 Billion

Travere Therapeutics has entered into a licensing agreement with Everest Medicines to acquire exclusive rights to the oral BTK...

TechnologyJune 9, 2026

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology behind ChatGPT, agreeing to pay...

CommercialJune 9, 2026

After a $1.2 billion deal, Innovent announces a phase 3 victory for Takeda-partnered ADC

IBA343 is an antibody-drug conjugate (ADC) that Takeda placed...

ClinicalJune 9, 2026

Parabilis Plans Phase 3 Desmoid Tumor Trial for Zolucatetide as It Pursues IPO

Parabilis Medicines is preparing to advance its lead drug...

InsightsJune 9, 2026

Top 10 Trends Redefining the Future of Medical Affairs

Executive Summary Medical affairs is undergoing one of the most significant transformations in its history. Traditionally positioned as a bridge between...

InsightsJune 9, 2026

Top 10 Infrastructure Priorities for AI-Driven Healthcare Enterprises

Executive Summary Artificial intelligence is rapidly becoming a foundational capability across healthcare and life sciences. Organizations are deploying AI to...

InsightsJune 9, 2026

Agentic AI in Pharma: The Emerging Operating Model for Pharmaceutical Innovation

Executive Summary Artificial intelligence has become a major focus across the pharmaceutical industry, driving investments in drug discovery, clinical development,...

InsightsJune 9, 2026

Clinical Trials Are Evolving into Strategic Data Assets

Executive Summary For decades, pharmaceutical companies have viewed clinical trials...

ClinicalJune 9, 2026

Survodutide Tolerability In Line With Class, Boehringer Executives Say

Boehringer Ingelheim spent the weekend highlighting survodutide’s ability to...

ClinicalJune 9, 2026

Tango Reports Early Pancreatic Cancer Data for Vopimetostat and Daraxonrasib Combination

Tango Therapeutics has stated that an experimental combination of its drug vopimetostat and Revolution Medicines’ daraxonrasib produced encouraging early...

InsightsJune 9, 2026

Top 10 Reasons Life Sciences Companies Are Reassessing Their Cloud Strategies

Cloud Strategies;Executive Summary Cloud computing has become deeply embedded across the life sciences industry. Pharmaceutical companies, biotech firms, healthcare organizations,...

InsightsJune 7, 2026

Top 10 Operational Bottlenecks Slowing AI Adoption in Pharma

Executive Summary Artificial intelligence has rapidly evolved from an emerging technology to a strategic capability across the pharmaceutical industry. Organizations...